Share this video  

WCM/EADO 2021 | Does radiotherapy elicit an abscopal effect?

Jeffrey Weber, MD, PhD, NYU Langone Medical Center, New York, NY, outlines a debate about wether radiotherapy elicits an abscopal effect where the shrinkage of untreated tumors takes place concurrently with shrinkage of the targeted tumor during local therapy. Dr Weber argues that radiotherapy does not elicit an abscopal effect. This interview took place during the 10th World Congress of Melanoma in conjunction with the 17th EADO Congress Interactive Virtual Meeting.


Jeffrey Weber, MD, PhD, has participated in consultancy work for Merck, Genentech, AstraZeneca, GSK, Novartis, Nektar, Medivation, Celldex, Incyte and EMD Serono; has participated in advisory boards for BMS; holds equity in Celldex, CytoMx and Altor; has participated in scientific advisory boards for Lion Bioscience, Celldex, CytoMx, Incyte and cCam; has received research support from BMS, Merck, GSK, Novartis, AstraZeneca, Mirati and Acetylon; and is named on patent for an ipilimumab biomarker and a PD-1 patent.